Pyxis Oncology (PYXS) Other Operating Expenses (2022 - 2025)

Pyxis Oncology (PYXS) has 4 years of Other Operating Expenses data on file, last reported at $2.4 million in Q4 2025.

• Other Operating Expenses for Q4 2025 came in at $2.4 million, down 88.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.4 million (down 88.86% YoY), and the FY2025 annual result was $2.4 million, down 88.86% from the prior year.
• Other Operating Expenses retreated to $2.4 million in Q4 2025 per PYXS's latest filing, from $21.0 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $172.2 million in Q4 2023 and troughed at -$43.0 million in Q4 2022.
• A 4-year average of $12.5 million and a median of $475000.0 in 2024 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2023 and 2025: Other Operating Expenses surged 500.85% in 2023, then slumped 88.61% in 2025.
• A 4-year view of Other Operating Expenses shows it stood at -$43.0 million in 2022, then surged by 500.85% to $172.2 million in 2023, then tumbled by 87.82% to $21.0 million in 2024, then tumbled by 88.61% to $2.4 million in 2025.
• Business Quant data shows PYXS's Other Operating Expenses at $2.4 million in Q4 2025, $21.0 million in Q4 2024, and $475000.0 in Q1 2024.